» Articles » PMID: 25916887

Systematic Comparison of MRI Findings in Pediatric Ependymoblastoma with Ependymoma and CNS Primitive Neuroectodermal Tumor Not Otherwise Specified

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2015 Apr 29
PMID 25916887
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ependymoblastoma (EBL), ependymoma (EP), and primitive neuroectodermal tumors of the central nervous system not otherwise specified (CNS-PNET NOS) are pediatric brain tumors that can be differentiated by histopathology in the clinical setting. Recently, we described specific MRI features of EBL. In this study, we compare standardized MRI characteristics of EBL with EP and CNS-PNET NOS in a series comprising 22 patients in each group.

Methods: All 66 centrally reviewed cases were obtained from the database of the German multicenter HIT trials. We systematically analyzed the initial MRI scans at diagnosis according to standardized criteria, and paired comparison was performed for EBL and EP, as well as for EBL and CNS-PNET NOS.

Results: We found differences between EBL and EP regarding age at diagnosis, MR signal intensity, tumor margin and surrounding edema, presence and size of cysts, and contrast enhancement pattern. Although MRI appearance of EBL shares many features with CNS-PNET NOS, we revealed significant differences in terms of age at diagnosis, tumor volume and localization, tumor margins, edema, and contrast enhancement.

Conclusion: This is the first study that systematically compares multiple parameters of MRI in pediatric EBL with findings in EP and CNS-PNET NOS. Although a definite differentiation by means of MRI alone might not be feasible in the individual case, we identify significant differences between these tumor entities.

Citing Articles

Parasites revive hope for cancer therapy.

Eissa M, Salem A, El Skhawy N Eur J Med Res. 2024; 29(1):489.

PMID: 39367471 PMC: 11453045. DOI: 10.1186/s40001-024-02057-2.


Whole-tumor histogram analysis of postcontrast T1-weighted and apparent diffusion coefficient in predicting the grade and proliferative activity of adult intracranial ependymomas.

Liu X, Han T, Wang Y, Liu H, Sun Q, Xue C Neuroradiology. 2024; 66(4):531-541.

PMID: 38400953 DOI: 10.1007/s00234-024-03319-w.


Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors.

Kamenova M, Kaneva R, Genova K, Gabrovsky N Adv Exp Med Biol. 2023; 1405:225-252.

PMID: 37452940 DOI: 10.1007/978-3-031-23705-8_8.


Ependymoblastoma with pulmonary metastasis in an adolescent: A case report.

Xu X, Li A, Xu X, Gong Q, Zhu S, Chu W Front Neurol. 2022; 13:964856.

PMID: 36016544 PMC: 9395982. DOI: 10.3389/fneur.2022.964856.


Ependymoma: Evaluation and Management Updates.

Ruda R, Bruno F, Pellerino A, Soffietti R Curr Oncol Rep. 2022; 24(8):985-993.

PMID: 35384591 PMC: 9249684. DOI: 10.1007/s11912-022-01260-w.


References
1.
Eberhart C, Brat D, Cohen K, Burger P . Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes. Pediatr Dev Pathol. 2000; 3(4):346-52. DOI: 10.1007/s100249910049. View

2.
Poussaint T . Magnetic resonance imaging of pediatric brain tumors: state of the art. Top Magn Reson Imaging. 2001; 12(6):411-33. DOI: 10.1097/00002142-200112000-00004. View

3.
Mermuys K, Jeuris W, Vanhoenacker P, van Hoe L, DHaenens P . Best cases from the AFIP: supratentorial ependymoma. Radiographics. 2005; 25(2):486-90. DOI: 10.1148/rg.252045095. View

4.
Kan P, Liu J, Hedlund G, Brockmeyer D, Walker M, Kestle J . The role of diffusion-weighted magnetic resonance imaging in pediatric brain tumors. Childs Nerv Syst. 2006; 22(11):1435-9. DOI: 10.1007/s00381-006-0229-x. View

5.
Dunham C, Sugo E, Tobias V, Wills E, Perry A . Embryonal tumor with abundant neuropil and true rosettes (ETANTR): report of a case with prominent neurocytic differentiation. J Neurooncol. 2007; 84(1):91-8. DOI: 10.1007/s11060-007-9346-y. View